Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy

NCT06538844 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06538844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06538844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy
Lead sponsor
Capital Medical University
Phase
Phase 2
Overall status
Completed
Start date
August 10, 2024
Completion date
March 15, 2025
Enrollment
134 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke